Oramed Pharmaceuticals Inc.
ORMP· Nasdaq
ORMPOramed Pharmaceuticals Inc.
Filed Mar 26, 2026 · 10-K · 85 days after period end · 0001213900-26-034835
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Revenue | $0.00 | — | $0.00 | $681.00K |
| Net Income | $10.01M | -$10.19M | $12.90M | -$8.26M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oramed Pharmaceuticals Inc. · CIK 1176309 · Engraved from SEC EDGAR
ended Dec 31, 2025 · filed Mar 26, 2026 · 85 d after period end
